Arteriosclerosis Flashcards
Chest pain: first line Inx
12-lead ECG
NSTEMI: Inx after ECG
Exercise tolerance ECG
Bloods: Troponin (useful in myocardial damage)
Diagnosis: exercise tolerance test - genuine ST depression
Angina
ECG: what does ST depression signify
Acidosis in myocardium
Chronic statble angina: definiton
Partly blocked coronary artery
When HR rises, ischaemia becomes significant and lactate accumulates
ECG: ST depression (acidosis in myocardium)
Chronic stable angina: Management (4 drugs) and other management
Aspirin: prevent platelet aggregation
Beta-blocker (slow HR): atenolol
Nitrates (GTN/ ISMN - PRN) - dilate arteries
Statin (Simvastatin/ atorvastatin)
Angioplasty/ CABG/Angiogram
Acei - For which CVS condition
Heart failure
Coronary arteries: supply
Left coronary artery: anterior wall/ anterio-lateral wall
Right: inferior wall
Angina: complication
If left untreated:
Acute myocardial infarction
ECG finding: acute myocardial infarction
ST elevation MI (STEMI)
Cardiogenic shock: which patient
When V1-V6 blocked (whole of left ventricle)
Left coronary artery blockage (both branches)
ECG finding: inferior STEMI.
Lead II, III & AVF
Right coronary artery
Heart attack (STEMI): management
Medical emergency (within 1-2 hours)
Unblock coronary artery: PCI, angioplasty
If not available, thrombolysis with tPA (alteplase or streptokinase)
Until then: aspirin & nitrates, beta-blocker & station (reduce ischaemia during transfer)
Risk factors & Management: CVS
Diet & exercise
Stop soking
Reduce BP: low salt, drugs
Lipids: statins
Management guidelines: Hypertension
ACE-inhibitor/ angiotensin II
CCB
Thiazide-like diuretic
Hypertension Management: Why is CCB first line for afro-carribean demo.
different Renin-angiotension system
Dilator would work best compared to renin blocker
Optimal medical therapy: HA
Intensive lifestyle modification Aspirin High dose station (atorvastatin 60-80mg) optimal BP control Assess T2DM
Aggressive management of BP and lipids improve survival
PCSK9 inhibitor: Used for what?
Used when statin contraindicated
PCSK9 protein controls LDL receptors
Inhibition of PCSK9 decreases LDL recycling -> lower cholesterol
Evolocumab: monoclonal antibody
Evolocumab (PCSK9 inhibitor): conclusion
Good relative risk (20%, preventing event) but non-significant improvement for absolute risk eg. death (0.1% in 3 years)